Previous 10 | Next 10 |
CARLSBAD, Calif. , Sept. 17, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) announces its and the University of Louisville's joint filing of a United States provisional patent application, entitled "Methods of inhibiting or treating coronavirus infection, and method...
CARLSBAD, Calif. , Aug. 31, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) announced today it has signed a contract with IRISYS LLC for the production of AS1411, Qualigen's lead drug candidate for the treatment of viral diseases including COVID-19. Preclinica...
CARLSBAD, Calif. , Aug. 28, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) announced today the addition of pharmaceutical executive Amy Broidrick to the company's Board of Directors. Ms. Broidrick's background includes key roles in the successful worl...
Alliance Global Partners upgrades Qualigen ( QLGN +4.0% ) to Buy with a $10 (107% upside) price target. In a note, analyst James Molloy regards the company as a "compelling opportunity" in cancer detection and treatment. More news on: Qualigen Therapeutics, Inc., Healthcare stocks news, ...
The USPTO has issued a new patent to Qualigen Therapeutics (NASDAQ: QLGN ) entitled "Devices and Methods for On-Line Whole Blood Treatment" regarding Company's Selective Target Antigen Removal System (STARS) technology. More news on: Qualigen Therapeutics, Inc., Healthcare stocks news,...
CARLSBAD, Calif. , Aug. 20, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the United States Patent and Trademark Office has issued patent No. 10,744,257 entitled "Devices and Methods for On-Line Whole Blood Treatment"...
For FQ1 , Qualigen Therapeutics ( QLGN -5.3% ) reported revenue of $0.9M (-40.4% Y/Y), led by a decrease in patient visits to physician offices, clinics and small hospitals amid pandemic, which reduced the number of FastPack tests performed. More news on: Qualigen Therapeutics, I...
Qualigen Therapeutics, Inc. (QLGN) Q1 2021 Results Conference Call August 18, 2020 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Michael Poirier - Chairman, President and CEO Christopher Lotz - Chief Financial Officer Conference Call Participants ...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Qualigen Therapeutics (NASDAQ: QLGN ) : FQ1 GAAP EPS of -$2.12. More news on: Qualigen Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Qualigen Therapeutics Inc. Company Name:
QLGN Stock Symbol:
NASDAQ Market:
Qualigen Therapeutics Inc. Website:
A look at the top 10 most actives in the United States American Rebel Holdings Inc. (AREB) rose 60.3% to $0.83355 on volume of 56,112,820 shares DatChat Inc. (DATS) rose 71.2% to $1.78 on volume of 33,845,116 shares Autonomix Medical Inc. (AMIX) rose 97.4% to $1.22 on volume of 33,054,234...
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.2493 on volume of 118,503,418 shares Qualigen Therapeutics Inc. (QLGN) rose 94.8% to $0.4 on volume of 100,863,101 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 20.0% to $0.098...